Results 241 to 250 of about 45,696 (262)

Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects

Pharmacology Research and Perspectives, 2015
Shampa Das, Jon Armstrong, Timi Edeki
exaly  

Ceftazidime Avibactam

Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
openaire   +1 more source

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Brian A Potoski, Ghady Haidar   +2 more
exaly  

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota

International Journal of Antimicrobial Agents, 2015
Mamun-Ur Rashid, Staffan Rosenborg, Georgios Panagiotidis   +2 more
exaly  

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo

Journal of Antimicrobial Chemotherapy, 2019
Stephan Göttig, Denia Frank, Michael Hogardt   +2 more
exaly  

Reply to “Aztreonam-Ceftazidime-Avibactam” May Not Be Enough

Clinical Infectious Diseases
Niaz Banaei, Stanley C Deresinski
openaire   +2 more sources

Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia

The Lancet Infectious Diseases, 2018
Andre C, Kalil, Michael, Klompas
openaire   +2 more sources

Ceftazidime and ceftazidime/avibactam

Endimiani, Andrea, Wright, Hugh
openaire   +1 more source

Pharmacotherapy Review of Ceftazidime-Avibactam.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2017
Amber, Yaeger, John, Kappes
openaire   +1 more source

Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2017
Benjamin Davido, Christine Lawrence, Martin Rottman   +2 more
exaly